Location History:
- Chester, NJ (US) (2019 - 2020)
- Saint Paul, MN (US) (2022 - 2023)
Company Filing History:
Years Active: 2019-2023
Title: The Innovative Contributions of Nancy Tich
Introduction
Nancy Tich is a prominent inventor based in Chester, NJ (US). She has made significant contributions to the field of medical technology, particularly in the treatment of Fragile X Syndrome. With a total of five patents to her name, Tich is recognized for her innovative approaches to addressing behavioral symptoms associated with this condition.
Latest Patents
One of Nancy Tich's latest patents focuses on the treatment of Fragile X Syndrome using cannabidiol (CBD). The technology outlines a method for transdermally administering an effective amount of CBD to alleviate one or more behavioral symptoms in affected individuals. This groundbreaking approach highlights the potential of CBD as a therapeutic agent in managing the challenges faced by those with Fragile X Syndrome.
Career Highlights
Nancy Tich is currently associated with Zynerba Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has garnered attention for its innovative nature and potential impact on patient care. Tich's dedication to improving the lives of individuals with Fragile X Syndrome is evident in her ongoing research and patent filings.
Collaborations
Some of Nancy Tich's notable coworkers include Marcel Bonn-Miller and Donna Gutterman. Their collaborative efforts contribute to the advancement of research in the field of cannabinoid therapies and their applications in treating various medical conditions.
Conclusion
Nancy Tich's contributions to the field of medical technology, particularly in the treatment of Fragile X Syndrome, underscore her role as an influential inventor. Her innovative patents and commitment to research continue to pave the way for new therapeutic options.